| 8.55 Data as of Jun 19 |  -0.08 / -0.93%Today’s Change | 4.41 Today|||52-Week Range 9.25 | +78.87% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Morneau Michael Chief Administrative Officer & VP-Finance |  Sale | 5/14/2013 | 20,000 | $7.75 | $155.0K | +4.91% |
Prokocimer Philippe G Chief Medical Officer | Sale | 5/24/2013 | 12,000 | $7.93 | $95.2K | +7.55% |
Bartizal Kenneth F Chief Development Officer | Sale | 5/24/2013 | 12,000 | $7.93 | $95.2K | +7.55% |
Bartizal Kenneth F Chief Development Officer | Sale | 5/14/2013 | 12,000 | $7.85 | $94.2K | +4.91% |
Prokocimer Philippe G Chief Medical Officer | Sale | 5/13/2013 | 12,000 | $7.65 | $91.8K | +13.55% |
Morneau Michael Chief Administrative Officer & VP-Finance |  Buy | 5/14/2013 | 20,000 | $4.00 | $80.0K | +4.91% |
Finn John Chief Scientific Officer | Sale | 5/14/2013 | 5,000 | $8.10 | $40.5K | +4.91% |
Finn John Chief Scientific Officer | Sale | 6/12/2013 | 3,000 | $9.08 | $27.2K | -2.06% |
Finn John Chief Scientific Officer | Sale | 5/10/2013 | 3,000 | $7.48 | $22.4K | +14.00% |
Bartizal Kenneth F Chief Development Officer | Sale | 6/04/2013 | 2,000 | $7.90 | $15.8K | +11.04% |
.
